ArticleCureus2025

Sustained Effects of Glucagon-Like Peptide-1 (GLP-1) Agonists on Blood Pressure in Obesity and Type 2 Diabetes: A Longitudinal Case Study.

Jimmy JosephPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.